Assetmark »

Vaneck Vectors Pharmaceutical etf shares owned by Assetmark

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Assetmark

Quarter filed Position value Share count Share price at filing
2024-12-31 $86k 999 86.28
2024-09-30 $617k 6.5k 95.03
2024-06-30 $561k 6.1k 91.48
2024-03-31 $553k 6.1k 90.70
2023-12-31 $446k 5.5k 81.37
2023-09-30 $211k 2.6k 79.86

More positions owned by Assetmark

Vanguard World Mega Grwth Ind (MGK)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Sm Cp Val Etf (VBR)
NVIDIA Corporation (NVDA)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Us Treas Bd Etf (GOVT)
Spdr Ser Tr Bloomberg High Y (JNK)

View all positions for Assetmark

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
J.Safra Asset Management
Mivtachim The Workers Social Insurance Fund
Miller Investment Management
Thrivent Financial for Lutherans
Adamsbrown Wealth Consultants
Two Sigma Investments
Prime Capital Investment Advisors
Bank of America Corporation
Morgan Stanley
Susquehanna International
Bnp Paribas Arbitrage, Snc
Independent Advisor Alliance

View all funds holding Vaneck Vectors Pharmaceutical etf